Across TCGA pan-cancer cohorts, MIR340 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR340’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR340 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR340 is over-expressed in tumor.

BRCA, LUAD, and LIHC are the cancer types where MIR340 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR340 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.151	.048	2	view →
LUAD	All	All	+0.205	.017	1	view →
LIHC	All	All	+0.074	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR340 RNA expression & survival · all MIR340 data types